Louis M Aledort

4PUBLICATIONS
4CO-AUTHORS
Aerodynamics (excl. hypersonic aerodynamics)Plasma physics; fusion plasmas; electrical dischargesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 09, 2021
In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended-half-life FVIII products or not?

Erik Berntorp, Snejana Krassova, Louis Aledort

|Mar 14, 2019
Why plasma-derived factor VIII?

Louis Aledort, Shannon L Carpenter, Adam Cuker

|Feb 13, 2019
The ongoing imperative for immune tolerance induction in inhibitor management.

Louis M Aledort

|Jul 11, 2018
Prophylaxis re-visited: The potential impact of novel factor and non-factor therapies on prophylaxis.

M Carcao, T Lambert, C Leissinger

Pageof 1

Frequent Collaborators

1 joint publications

M Carcao

1 joint publications

Roshni Kulkarni

1 joint publications

Guy Young

1 joint publications

Erik Berntorp